Alexa Fluor® 647 Anti-IMPDH2 antibody [EPR8365(B)],Abcam,AB310178

How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents .

Host

Rabbit

Reactivity

Human

Application

Target Binding Affinity, Flow Cyt (Intra), ICC/IF, IHC-P, Antibody Labelling

Conjugate

Alexa Fluor® 647

Platform ID

BAB687304402

Abcam

Headquarters

Discovery Drive Cambridge Biomedical Campus Cambridge CB2 0AX UK

Abcam

Contact

Tel: +44 (0)1223 696000
Fax: +44 (0)1223 215 215

Email:

[email protected]

Product Specifications
Scientific Background

Specifications

NameAlexa Fluor® 647 Anti-IMPDH2 antibody [EPR8365(B)]
Cat. No.AB310178
HostRabbit
IsotypeIgG
ReactivityHuman
ConjugationAlexa Fluor® 647
ApplicationTarget Binding Affinity, Flow Cyt (Intra), ICC/IF, IHC-P, Antibody Labelling
ClonalityMonoclonal
Clone NumberEPR8365(B)
ImmunogenThe exact immunogen used to generate this antibody is proprietary information.
PurityAffinity purification Protein A
Appearance/FormLiquid
ShippingBlue Ice
FormulationpH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 30% Glycerol (glycerin, glycerine), 1% BSA
Storage-20°C
Regulatory StatusResearch Use Only

Scientific Background

Target data Catalyzes the conversion of inosine 5'-phosphate (IMP) to xanthosine 5'-phosphate (XMP), the first committed and rate-limiting step in the de novo synthesis of guanine nucleotides, and therefore plays an important role in the regulation of cell growth (PubMed : 7763314, PubMed : 7903306). Could also have a single-stranded nucleic acid-binding activity and could play a role in RNA and/or DNA metabolism (PubMed : 14766016). It may also have a role in the development of malignancy and the growth progression of some tumors. See full target information IMPDH2

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.